Department of Radiation Oncology, ACTREC/TMH, Tata Memorial Centre, Mumbai, India.
Department of Epidemiology & Clinical Trials Unit, ACTREC/TMH, Tata Memorial Centre, Mumbai, India.
Pract Radiat Oncol. 2018 Sep-Oct;8(5):e275-e284. doi: 10.1016/j.prro.2018.01.010. Epub 2018 Feb 4.
The role of early adjuvant radiation therapy (RT) in patients with atypical meningioma remains controversial. The goal of this work was to report the impact of timing of RT on outcomes in atypical meningioma.
Patients of atypical meningioma were identified through electronic search of institutional database. Following surgery, RT was delivered either in upfront adjuvant setting (early adjuvant RT) or after recurrence/progression (salvage RT).
There were 51 patients in the early adjuvant RT group and 30 patients in the salvage RT group. Six of 51 (12%) patients in the early adjuvant RT group recurred/progressed compared with 34 of 35 (97%) patients kept on observation after initial surgery. Thirty of these 34 patients received salvage RT, mostly after reexcision. Twelve of 30 (40%) patients recurred/progressed after salvage RT, compared with 6 of 51 (12%) patients after early adjuvant RT (P = .003). Post-RT 5-year progression-free survival was significantly better for early adjuvant RT compared to salvage RT (69% vs 28%, log-rank P < .001).
Within the limitations of any retrospective analysis, upfront early adjuvant RT can significantly reduce the risk of local recurrence/progression in atypical meningiomas compared with initial observation. A sizeable proportion of patients who are observed initially recur/progress over time necessitating salvage therapy; however, reexcision followed by salvage RT may not be as effective as early adjuvant RT.
早期辅助放疗(RT)在非典型脑膜瘤患者中的作用仍存在争议。本研究旨在报告 RT 时机对非典型脑膜瘤患者结局的影响。
通过电子搜索机构数据库确定非典型脑膜瘤患者。手术切除后,行早期辅助 RT(辅助放疗)或复发/进展后行挽救性 RT(挽救性放疗)。
早期辅助 RT 组有 51 例患者,挽救性 RT 组有 30 例患者。早期辅助 RT 组 6 例(12%)患者复发/进展,而初始手术后观察的 35 例患者中有 34 例(97%)患者复发/进展。其中 34 例患者接受挽救性 RT,大多数在再次切除后。30 例接受挽救性 RT 的患者中,12 例(40%)患者复发/进展,而 51 例接受早期辅助 RT 的患者中,6 例(12%)患者复发/进展(P =.003)。与挽救性 RT 相比,早期辅助 RT 后 5 年无进展生存率显著提高(69% vs 28%,log-rank P <.001)。
在任何回顾性分析的局限性内,与初始观察相比,早期辅助 RT 可显著降低非典型脑膜瘤局部复发/进展的风险。最初观察的患者中,有相当一部分随着时间的推移会复发/进展,需要挽救性治疗;然而,再次切除后行挽救性 RT 可能不如早期辅助 RT 有效。